Is ATTO or COLL more profitable?

COLL runs the higher net margin — ATTO at -4490.89% versus COLL at 5.93%.

Attovia Therapeutics, Inc. (ATTO) vs Collegium Pharmaceutical, Inc. (COLL)

A side-by-side comparison of Attovia Therapeutics, Inc. and Collegium Pharmaceutical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ATTO

Attovia Therapeutics, Inc.

$762M

$17.71HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

COLL

Collegium Pharmaceutical, Inc.

$718M

$22.15HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

Total return — ATTO vs COLL

growth of $100 · dividends reinvested · last 1y

ATTO -17.8% (-17.8%/yr)COLL -38.8% (-38.8%/yr)ATTO compounded faster over this window

ATTO COLL

ATTO vs COLL: by the numbers

•ATTO is the larger company ($762M vs $718M market cap).
•COLL is profitable (5.93% net margin) while ATTO runs a net loss (-4490.89%).

Metrics side by side

Valuation

Metric	ATTO	COLL
P/E ratio	N/A	17.86
PEG ratio	N/A	1.00
P/S ratio	N/A	0.89
P/B ratio	N/A	2.30
EV / EBITDA	N/A	2.86
FCF yield	N/A	45.70%

Profitability

Metric	ATTO	COLL
Gross margin	40.44%	60.02%
Operating margin	-4974.74%	19.61%
Net margin	-4490.89%	5.93%
ROE	-40.21%	15.36%
ROIC	-42.83%	6.11%

Growth (annualized)

Metric	ATTO	COLL
Revenue CAGR (5Y)	N/A	19.91%
EPS CAGR (5Y)	N/A	20.48%
FCF CAGR (5Y)	N/A	26.38%
Total return CAGR (5Y)	N/A	2.15%

Frequently asked

Is ATTO or COLL more profitable?: COLL runs the higher net margin — ATTO at -4490.89% versus COLL at 5.93%.

Go deeper

Full ATTO analysis Full COLL analysis Interactive comparison tool

Dig into the metrics

Collegium Pharmaceutical P/E ratio Attovia Therapeutics ROE Collegium Pharmaceutical ROE Attovia Therapeutics operating margin Collegium Pharmaceutical operating margin Attovia Therapeutics revenue growth Collegium Pharmaceutical revenue growth Attovia Therapeutics free cash flow Collegium Pharmaceutical free cash flow

Attovia Therapeutics & Collegium Pharmaceutical appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.